Please assess the completion status of the following clinical trial:

Trial Title: Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia.

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Written informed consent is obtained from the children's parent(s) / legal guardian(s) before any study-related activity is carried out~2. The child is able to provide written informed assent, where this is required according to national legislation, before any study related activity is carried out~3. The child has been diagnosed as having achondroplasia documented by clinical diagnosis~4. The child is between 0 years and 10 years of age, inclusive, on the date of consent / assent~5. The investigator has considered the family and prospective participating child being able to comply with the study procedures~Exclusion Criteria:~1. The child has a diagnosis of hypochondroplasia or any short stature condition other than achondroplasia (eg, spondyloepiphyseal dysplasia congenital \[SEDC\], pseudoachondroplasia, trisomy 21)~2. The child has any medical condition that may impact growth or where the treatment is known to impact growth, such as but not limited to hypothyroidism or hyperthyroidism, insulin-requiring diabetes mellitus, autoimmune inflammatory disease (including celiac disease, systemic lupus erythematosus \[SLE\], juvenile dermatomyositis, scleroderma, and others), autonomic neuropathy, or inflammatory bowel disease~3. Treatment in the previous 12 months prior to consent and assent with growth hormone, insulin-like growth factor 1 (IGF-1), anabolic steroids, or any other drug expected to affect growth velocity~4. Any surgery that affects the growth plate of the long bones that is planned, or has occurred in the past 18 months~5. Participation in any interventional study (investigational product or device) for treatment of achondroplasia or short stature~6. Has had bone-related surgery impacting assessment of anthropometric measurements or is expected to have it during the study period. Children with previous limb-lengthening surgery may enroll if surgery occurred at least 18 months prior to the date of consent/assent and healing is complete without sequelae as determined by the investigator~7. Has any condition that in the view of the investigator places the child at high risk of poor compliance with the visit schedule or of not completing the study.~8. Any concurrent disease or condition that in the view of the investigator would interfere with study participation

- Gender: ALL
- Minimum Age: 0 Years
- Maximum Age: 15 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).